Merck & Co Inc - Ends Favezelimab Clinical Development Program, Stops Enrollment in Keyform-008 Trial
默沙东 - 结束Favezelimab临床开发项目,停止在Keyform-008试验中的招生
Merck & Co Inc - Ends Favezelimab Clinical Development Program, Stops Enrollment in Keyform-008 Trial
默沙东 - 结束Favezelimab临床开发项目,停止在Keyform-008试验中的招生
使用浏览器的分享功能,分享给你的好友吧